Skip to main content

Mouse Monoclonal BXE antibody. Carrier free. Suitable for ICC/IF, Inhib and reacts with Clostridium botulinum samples. Cited in 1 publication.

Be the first to review this product! Submit a review

Publications

Key facts

Isotype

IgG

Host species

Mouse

Storage buffer

Constituents: Tissue culture supernatant

Form

Liquid

Clonality

Monoclonal

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
ICC/IFInhib
Clostridium botulinum
Expected
Expected

Expected
Expected

Species

Clostridium botulinum

Dilution info
1/50
Notes

-

Expected
Expected

Species

Clostridium botulinum

Dilution info

Use at an assay dependent concentration.

Notes

-

Target data

Function

Botulinum neurotoxin type EBotulinum toxin causes flaccid paralysis by inhibiting neurotransmitter (acetylcholine) release from the presynaptic membranes of nerve terminals of eukaryotic host skeletal and autonomic nervous system, with frequent heart or respiratory failure. Precursor of botulinum neurotoxin E which has 2 coreceptors; complex polysialylated gangliosides found on neural tissue and specific membrane-anchored proteins found in synaptic vesicles. Receptor proteins are exposed on host presynaptic cell membrane during neurotransmitter release, when the toxin heavy chain (HC) binds to them (PubMed:19476346, PubMed:19650874). Upon synaptic vesicle recycling the toxin is taken up via the endocytic pathway. When the pH of the toxin-containing endosome drops a structural rearrangement occurs so that the N-terminus of the HC forms pores that allows the light chain (LC) to translocate into the cytosol (PubMed:22720883). Once in the cytosol the disulfide bond linking the 2 subunits is reduced and LC cleaves its target protein on synaptic vesicles, preventing their fusion with the cytoplasmic membrane and thus neurotransmitter release (By similarity). Electrical stimulation increases uptake of toxin, probably by transiently exposing a receptor found in eukaryotic target synaptic vesicles (PubMed:19476346, PubMed:19650874). Uses the large lumenal domain of synaptic vesicle glycoproteins 2A and 2B (SV2A and SV2B) but not SV2C as receptor; an N-linked glycan of SV2 is essential for receptor function (PubMed:18815274, PubMed:19476346). Host cell gangliosides are also required for neurotoxin uptake and full toxicity (PubMed:18815274, PubMed:19650874). BoNT/E is a 'coincidence detector'; it requires simultaneous binding to coreceptor GT1b and low pH to transform into a membrane-bound, oligomeric channel (PubMed:22720883). Requires trypsinization and reduction before it can be used in assays in vitro (PubMed:8294407).Botulinum neurotoxin E light chainHas proteolytic activity (PubMed:8243676, PubMed:8294407, PubMed:9886085). After translocation into the eukaryotic host cytosol, inhibits neurotransmitter release by acting as a zinc endopeptidase that catalyzes the hydrolysis of the '180-Arg-|-Ile-181' bond in SNAP25 (PubMed:8243676, PubMed:8294407, PubMed:9886085). Hydrolyzes the '185-Arg-|-Ile-186' bond of mouse SNAP23, but not in human which has a different sequence (PubMed:9886085). Recognizes the '146-Met--Asp-186' region of SNAP25 (PubMed:9886085). The reaction mechanism probably has a nucleophilic water held in place by Glu-213 (PubMed:15157097, PubMed:15938619). Reduction of the interchain disulfide bond occurs in the host cytosol and probably prevents retrotranslocation into the synaptic vesicle (PubMed:17666397).Botulinum neurotoxin E heavy chainResponsible for host epithelial cell transcytosis, host nerve cell targeting and translocation of light chain (LC) into host cytosol (PubMed:17666397). Composed of 3 subdomains; the translocation domain (TD), and N-terminus and C-terminus of the receptor-binding domain (RBD). The RBD is responsible for the adherence of the toxin to the cell surface (PubMed:10413679). It probably simultaneously recognizes 2 coreceptors; polysialated gangliosides and either of the receptor proteins SV2A and SV2B in close proximity on host synaptic vesicles (PubMed:18815274, PubMed:19476346, PubMed:19650874). The N-terminus of the TD wraps an extended belt around the perimeter of the light chain (LC), protecting Zn(2+) in the active site (PubMed:19118561). The belt may also prevent premature LC dissociation from the translocation channel and protect toxin prior to translocation (PubMed:17907800). The TD inserts into synaptic vesicle membrane to allow translocation into the host cytosol (By similarity). Responsible for adherence of the toxin to the cell surface; HC alone prevents uptake of whole toxin by neural cells, and delays paralysis onset by 154% (PubMed:10413679). Significantly decreases uptake and toxicity of whole BoNT/E, but also interferes with uptake of BoNT/C; binds GT1b in vitro (PubMed:19650874). Binds to synaptic vesicle glycoproteins SV2A and SV2B which serve as coreceptors with gangliosides (PubMed:18815274, PubMed:19650874). Interaction with SV2 proteins requires SV2 glycosylation (PubMed:19476346). HC alone significantly decreases uptake and toxicity of whole BoNT/E (PubMed:19650874). HC is responsible for translocation of LC into the host cytosol; an intact disulfide bond between the 2 subunits is required for translocation, which is reduced upon contact with the host cytosol (PubMed:17666397).

Alternative names

Recommended products

Mouse Monoclonal BXE antibody. Carrier free. Suitable for ICC/IF, Inhib and reacts with Clostridium botulinum samples. Cited in 1 publication.

Key facts

Isotype

IgG

Form

Liquid

Clonality

Monoclonal

Carrier free

Yes

Clone number

209F2

Purity

Tissue culture supernatant

Specificity

BoTox-E (2-17) 100%; BoTox-E 100%
Does not cross react with BoTox-A, BoTox-B, BoTox-C or BoTox-F (1-16)

Concentration
Loading...
Purification notes

Sterile filtered culture supernatant.

Storage

Shipped at conditions

Blue Ice

Appropriate short-term storage conditions

+4°C

Appropriate long-term storage conditions

-20°C

Aliquoting information

Upon delivery aliquot

Storage information

Avoid freeze / thaw cycle

Notes

Abcam is leading the way to address reproducibility in scientific research with our highly validated recombinant monoclonal and recombinant multiclonal antibodies. Search & select one of Abcam's thousands of recombinant alternatives to eliminate batch-variability and unnecessary animal use.

If you do not find a host species to meet your needs, our catalogue and custom Chimeric range provides scientists the specificity of Abcam's RabMAbs in the species backbone of your choice. Remember to also review our range of edited cell lines, proteins and biochemicals relevant to your target that may help you further your research goals.

Abcam antibodies are extensively validated in a wide range of species and applications, so please check the reagent specifications meet your scientific needs before purchasing. If you have any questions or bespoke requirements, simply visit the Contact Us page to send us an inquiry or contact our Support Team ahead of purchase.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.

Activity summary

Clostridium botulinum E toxoid often referred to as botulinum toxin type E mechanically inhibits neurotransmitter release by cleaving the SNAP-25 protein a component of the SNARE complex essential for synaptic vesicle docking and fusion. It is produced by Clostridium botulinum bacteria which are anaerobic and spore-forming. The mass of botulinum toxin type E is approximately 150 kDa. It is expressed in environments where Clostridium botulinum thrives typically in poorly preserved food and anaerobic conditions.

Biological function summary

Botulinum toxin type E hinders nerve signal transmission by blocking acetylcholine release at the neuromuscular junction resulting in muscle paralysis. It does not function as a part of a complex in its active form but its precursor protein structure refolds into an active form within the host. This toxin affects peripheral cholinergic synapses including neuromuscular junctions autonomic ganglia and postganglionic parasympathetic nerve endings.

Pathways

The effects of botulinum toxin type E influence the neurotransmission pathway and the synaptic vesicle cycle. The toxin by acting on SNAP-25 disrupts normal synaptic vesicle fusion with the presynaptic membrane thereby interrupting neurotransmitter release. SNAP-25 a target of many SNARE proteins is critical for vesicle-mediated transport processes specifically in the secretory pathway associated with neurotransmitter release.

Associated diseases and disorders

Botulinum toxin type E is implicated in botulism a condition characterized by descending symmetric paralysis that can be life-threatening. The link between botulinum toxin type E and SNAP-25 is central to the clinical symptoms of the disorder as the blockage of neurotransmitter release by SNAP-25 cleavage leads to the paralysis. Additionally researchers explore therapeutic applications of the toxin in conditions such as cervical dystonia. The toxin-target connection with the SNARE complex particularly SNAP-25 informs both understanding and treatment of these neuromuscular and neurological disorders.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

0 product images

    Downloads

    Product protocols

    For this product, it's our understanding that no specific protocols are required. You can:

    Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

    For licensing inquiries, please contact partnerships@abcam.com